It never occurred to me when I sat at Rose’s bedside
that she would be any different than the scores of patients I had treated with
radioactive iodine for an overactive thyroid.
And as with the others, it wasn’t long before her tremulousness, typical
of the disease, also infected me; I felt my body trembling in rhythm with
hers.
It was 1950. I
had accepted a fellowship in radioactive iodine research at the Beth Israel
Hospital in Boston without even knowing what radioactive iodine was. Few academicians anticipated that this
isotope would herald the field of nuclear medicine. That it would play such a significant role in
my life was hardly in my mind; I initially thought of the job merely as a
stepping-stone to an appointment as a Resident in Internal Medicine. In fact it was to lead me to my wife and to a
successful move to Israel . But that’s another story.
Rose K., age thirty-five, looking fifty-five, was a mother of
three children; the youngest was five years old. Her husband, age forty, hadn’t been employed
for several years because of unexplained bleeding in his extremities – more on
this in a moment. They lived in a
three-room apartment in a public housing project, subsisting on welfare checks
and food stamps. One child had a seizure
disorder, another, asthma. Rose had
little reason to smile. On the contrary,
she was haggard, appearing malnourished with cracked lips and a
vitamin-deficient, smooth, red tongue.
Her gaunt cheeks sagged, as did the skin of her arms, indications of a
recent twenty-pound weight loss. Her
skin was warm and her pulse, fast. All
of these signs were typical of patients with hyperthyroidism, an overactive
thyroid. But why didn’t she have
protuberant eyes and an enlarged thyroid gland, other findings typical of this
disease? I would soon learn the answer.
At this point it was obvious that I would have another
candidate to add to my growing research study dealing with the use of
radioactive iodine in the treatment of hyperthyroidism. A few more and a pioneer publication could be
expected, maybe even a presentation at a national medical meeting. This sequence didn’t unfold quite as I
imagined it would.
I explained to Rose the nature of the radioactive iodine test
to be performed the next morning. It
would measure the function of her thyroid gland, information essential for
arriving at a proper treatment dose of radioactive iodine. I even anticipated this treatment by
explaining that radiation from the dose I would give her would gradually shrink
her gland over six to twelve weeks and, thereby, reduce its function. Most patients would be cured by the end of
that period.
The following morning Rose was brought to my lab in a wheel
chair – her muscles too weakened to permit walking. I gave her a drink of a small dose of
radioactive iodine. The following
morning she returned for measurement of the amount of radioactive iodine
collected by her thyroid gland. In
normal patients the answer would be 15-30%.
In a patient with an overactive gland it would be 35-80%. Imagine my dismay when Rose’s measurement was
1%. First I blamed my technique. Had I given her water instead of radioactive
iodine? The presence of a significant
amount of radioactive iodine in a urine sample discounted that
possibility. Next I blamed the
equipment. I checked the electrical
connections on our homemade, primitive set-up.
Finally a successful check of a known quantity of radioactive material
proved that I had to look elsewhere for the answer.
After Rose returned to her room, someone suggested that she
might have been taking diet pills and just neglected to tell us. In that era diet pills contained thyroid
extract in quantities sufficient not only to block thyroid function (and reduce
the entrance of iodine into the gland) but also to cause adverse effects on the
body, which simulate the findings of an overactive thyroid. We called the unit
and had the intern ask the patient if she was taking diet pills. The intern spoke with me. “Rose appeared irate and emphatically denied
this.”
I thereupon requested the nurse to send Rose back to the lab
for “retesting.” During the time that
she was with me – I feigned a change in technique for measuring her thyroid
activity – the nurses inspected Rose’s bedside table and locker. Lo and behold, two bottles filled with
thyroid pills were found! The nurse
phoned with this startling finding. The
mystery of hyperthyroidism associated with low iodine uptake was solved, as was
the absence of protruding eyes and an enlarged thyroid gland. A dose as little as four tablets a day would
mimic hyperthyroidism.
I took Rose into a private office and confronted her. “Rose, tell me about the bottles of thyroid
pills in your belongings.”
At first she looked at me with scorn. I suppose it was when she realized that I
cared about her, that she broke down, sobbing, “I want to die.” In the ensuing hour her tale unfolded. More than depressed, she was angry – angry at
life but more specifically, at her husband.
“He’s never held down a job. He
just sits around all day listening to the radio or studying a racing form. Of course, that is, when he’s not in the
hospital.”
“Why,” I asked, “does he need to be in the hospital?”
“‘Need to be in the hospital?’
That’s funny. He’ll kill me if I
tell you. Oh, what the hell! I told you that he has bleeding in his arms
and legs. Your blood department has been
struggling to diagnose a rare bleeding disease.
Well, there is none. He just
bangs his legs against the toilet bowl and his arms against the sink until they
are black and blue. He loves being
fussed over by the doctors and nurses.”
“But, Rose, what’s this got to do with your taking thyroid
pills?” She had admitted to taking
fifteen to twenty a day, a dose that, if continued, would eventually kill
her. She knew it. I suggested that, “there are faster ways of
killing yourself.”
“That’s the point. I
wanted to make my husband suffer as he watched me dying, not that he could care
much once I’m gone.” I was now getting
over my head into psychiatric waters that called for the involvement of a
psychiatrist; this I arranged for both Rose and her husband. (The latter’s hematologists on first hearing
of the self-inflicted lesions wanted to kill him for wasting their precious
time and resources.)
Putting a name thyrotoxicosis
factitia on Rose’s condition didn’t help except as the title of her case report that was published in a medical journal a year after our first
encounter. Rose was checked in the
thyroid clinic ten months after stopping thyroid pills; her gland function was
normal.
It is a sad commentary that neither my memory nor the article gives any
indication of the family’s psychiatric follow-up. It’s not conceivable that I cared only about
getting my name in the medical literature.
Or is it?
No comments:
Post a Comment